- Home
- AMLX vs PTON Comparison
AMLX vs PTON Comparison
Compare AMLX & PTON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMLX | PTON |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | AMLX | PTON |
|---|---|---|
| Price | $34.54 | $5.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $21.56 | $7.89 |
| AVG Volume (30 Days) | 3.5M | ★ 8.3M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 65.46 | ★ 146.67 |
| EPS | N/A | ★ 0.14 |
| Revenue | ★ $380,786,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.44 |
| P/E Ratio | ★ N/A | $37.86 |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $9.15 | $3.65 |
| 52 Week High | $41.14 | $9.20 |
Technical Indicators
Market Signals| Indicator | AMLX | PTON |
|---|---|---|
| Relative Strength Index (RSI) | 71.92 | 45.67 |
| Support Level | $12.54 | $5.49 |
| Resistance Level | $41.14 | $5.62 |
| Average True Range (ATR) | 2.27 | 0.18 |
| MACD | 0.63 | -0.01 |
| Stochastic Oscillator | 75.83 | 55.88 |
Price Performance
Historical ComparisonAbout AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
About PTON Peloton Interactive Inc.
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Products derive revenue from the portfolio of Connected Fitness Products and related accessories, as well as Precor-branded fitness products, delivery and installation services, Peloton Bike portfolio rental products, extended warranty agreements, branded apparel, and commercial service contracts. Subscription revenue is derived from monthly Subscription fees. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from International markets.